Science. 1992 May 8;256(5058):794-9.

Gaucher disease: new molecular approaches to diagnosis and treatment.

Source

Department of Molecular, Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037.

Abstract

Gaucher disease is characterized by the accumulation of glucocerebroside, leading to enlargement of the liver and spleen and lesions in the bones. It is caused by an inherited deficiency of the enzyme glucocerebrosidase. Many mutations exist, but four of these account for over 97% of the mutations in Ashkenazi Jews, the population group in which Gaucher disease is the most common. Although there is a strong relation between the mutations and disease manifestations, genetic counseling is made difficult by the fact that within each genotype there is considerable variability in the severity of the disease. Intravenous infusion of glucocerebrosidase is an effective treatment, but the availability of enzyme replacement therapy is limited by its high cost. Marrow transplantation is also effective in treating the disease, but is rarely performed because of the risks involved. In the future gene transfer may become the treatment of choice.

PMID:: 1589760; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Glucosylceramidase

Grant Support

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease. [Am J Hum Genet. 2000]
Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.
Koprivica V, Stone DL, Park JK, Callahan M, Frisch A, Cohen IJ, Tayebi N, Sidransky E. Am J Hum Genet. 2000 Jun; 66(6):1777-86. Epub 2000 May 4.
Review [From gene to disease; Gaucher disease]. [Ned Tijdschr Geneeskd. 2005]
Review [From gene to disease; Gaucher disease].
Hollak CE, Boot RG, Poorthuis BJ, Aerts JM. Ned Tijdschr Geneeskd. 2005 Sep 24; 149(39):2163-6.
Review [Molecular studies of Gaucher disease]. [Rinsho Byori. 1996]
Review [Molecular studies of Gaucher disease].
Eto Y, Ida H. Rinsho Byori. 1996 Apr; 44(4):327-34.
Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus. [Mol Genet Metab. 1998]
Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus.
Reissner K, Tayebi N, Stubblefield BK, Koprivica V, Blitzer M, Holleran W, Cowan T, Almashanu S, Maddalena A, Karson EM, et al. Mol Genet Metab. 1998 Apr; 63(4):281-8.
[Molecular diagnosis and gene therapy for Gaucher disease]. [Nihon Rinsho. 1993]
[Molecular diagnosis and gene therapy for Gaucher disease].
Ohashi T. Nihon Rinsho. 1993 Sep; 51(9):2300-7.

See reviews... See all...

Cited by 19 PubMed Central articles

Type 1 Gaucher disease: significant disease manifestations in "asymptomatic" homozygotes. [Arch Intern Med. 2010]
Type 1 Gaucher disease: significant disease manifestations in "asymptomatic" homozygotes.
Balwani M, Fuerstman L, Kornreich R, Edelmann L, Desnick RJ. Arch Intern Med. 2010 Sep 13; 170(16):1463-9.
Comparative gene expression profiling between human cultured myotubes and skeletal muscle tissue. [BMC Genomics. 2010]
Comparative gene expression profiling between human cultured myotubes and skeletal muscle tissue.
Raymond F, Métairon S, Kussmann M, Colomer J, Nascimento A, Mormeneo E, García-Martínez C, Gómez-Foix AM. BMC Genomics. 2010 Feb 22; 11:125. Epub 2010 Feb 22.
Human chitotriosidase polymorphisms G354R and A442V associated with reduced enzyme activity. [Blood Cells Mol Dis. 2007]
Human chitotriosidase polymorphisms G354R and A442V associated with reduced enzyme activity.
Lee P, Waalen J, Crain K, Smargon A, Beutler E. Blood Cells Mol Dis. 2007 Nov-Dec; 39(3):353-60. Epub 2007 Aug 10.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Gene (OMIM)
Gene records associated with Online Mendelian Inheritance in Man (OMIM) records that cite the current articles in their reference lists.
Nucleotide (Weighted)
Nucleotide records associated with the current articles through the Gene database. These are the related sequences on the Gene record that are added manually by NCBI.
OMIM (calculated)
Online Mendelian Inheritance in Man (OMIM) records that include the current articles as references in the light bulb links within or in the citations at the end of the OMIM record. The references available through the light bulb link are collected using the PubMed related articles algorithm to identify records with similar terminology to the OMIM record.
OMIM (cited)
Online Mendelian Inheritance in Man (OMIM) records that include the current articles as reference cited at the end of the OMIM record.
Protein (Weighted)
Protein records associated with the current articles through related Gene database records. These are the related sequences on the Gene record that are added manually by NCBI.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Gaucher disease: new molecular approaches to diagnosis and treatment.
Gaucher disease: new molecular approaches to diagnosis and treatment.
Science. 1992 May 8 ;256(5058):794-9.

PubMed
Characterization of chemical constituents in Scutellaria baicalensis with antian...
Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma.
Clin Cancer Res. 2005 May 15 ;11(10):3905-14.

PubMed
A bispecific recombinant immunotoxin, DT2219, targeting human CD19 and CD22 rece...
A bispecific recombinant immunotoxin, DT2219, targeting human CD19 and CD22 receptors in a mouse xenograft model of B-cell leukemia/lymphoma.
Clin Cancer Res. 2005 May 15 ;11(10):3879-88.

PubMed
Triplet repeat mutations in human disease.
Triplet repeat mutations in human disease.
Science. 1992 May 8 ;256(5058):784-9.

PubMed
Markers of adenocarcinoma characteristic of the site of origin: development of a...
Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.
Clin Cancer Res. 2005 May 15 ;11(10):3766-72.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: